跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维达莎 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Azacitidine for Injection
Approved
化学药品
Azacitidine for Injection
Bristol-Myers Squibb Pharma EEIG
🇨🇳 National Medical Products Administration
Approval Date
Feb 14, 2022
Approval ID
8Fekkn0lsEg
Company
Bristol-Myers Squibb Pharma EEIG
Type
化学药品
Approval Details
Approval Id
8Fekkn0lsEg
Approval Number
国药准字HJ20170238
Generic Name
注射用阿扎胞苷
Generic Name En
Azacitidine for Injection
Trade Name
维达莎
Drug Type
化学药品
Dosage Form
注射剂
Strength
100mg
Reg Date
2022-02-14
Expired Date
2027-02-13
Company Name
Bristol-Myers Squibb Pharma EEIG
Production Company Name
Baxter Oncology GmbH
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Production Company Detail Path
/organization/baxter-oncology-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 14, 2022
Approval ID
8Fekkn0lsEg
Type
化学药品
Back to NMPA Approvals